Evidence-based reads on GLP-1s, metabolic health, longevity science, and what it actually takes to feel better.
GLP-1 receptor agonists were originally developed for type 2 diabetes — but their dramatic weight loss effects have made them the most talked-about medications in a generation. Here's what the science actually says.
Read Article →Clinical trials show 8–15% average body weight loss. But what does that mean in practice, and who responds best?
Appetite suppression is real — but so are GI side effects. Here's how to eat well during the first 12 weeks.
Emerging research suggests GLP-1s may reduce cardiovascular events by 20%. The longevity implications are significant.
Some patients report reduced food noise, anxiety, and even alcohol cravings. Researchers are starting to take notice.
Brand-name costs over $1,000/month. Compounded versions cost 5–8× less. Is there a meaningful clinical difference?
GLP-1s reduce appetite broadly — including protein intake. A few simple strategies protect muscle mass during treatment.